Please assess the completion status of the following clinical trial:

Trial Title: HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* • Cases (PLWHIV + COVID-19)~  1. Any gender~ 2. At least 18 years of age~ 3. Documented HIV-1 infection~ 4. Confirmed SARS-CoV-2 infection by documented, or patient-reported, positive result on PCR testing of a nasopharyngeal or respiratory sample, before 1st April 2021~     * Controls (COVID-19)~  <!-- -->~  1. Any gender~ 2. At least 18 years of age~ 3. No documented HIV-1 infection~ 4. Confirmed SARS-CoV-2 infection by documented, or patient-reported, positive result on PCR testing of a nasopharyngeal or respiratory sample, before 1st April 2021~ 5. Meet the matching criteria~For comparing PLWHIV \& COVID-19 versus HIV seronegative COVID-19 patients, a 1:1 matching will be performed according to the following criteria:~* Age (+/- 5 years)~* Sex~* Ethnicity (where available)~* Month of COVID-19 diagnosis (+/- 2 months)~* COVID-19 diagnosis inpatient OR~* COVID-19 diagnosis outpatient (ambulatory)~* Controls (PLWHIV)~  1. Any gender~ 2. At least 18 years of age~ 3. Documented HIV-1 infection~ 4. No evidence of SARS-CoV-2 infection~ 5. Meet the matching criteria~For comparing PLWHIV \& COVID-19 versus PLWHIV without COVID-19, a 1:2 matching for similar risk of acquiring COVID-19 will be performed according to the following criteria:~* Age (+/- 5 years)~* Sex~* Ethnicity (where available)~Exclusion Criteria~For cases (PLWHIV + COVID-19) and for COVID-19 only controls:~* COVID-19 diagnosed based on clinical criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PLWHIV with COVID-19 cases (Type: None): Patients who are at least 18 years of age with documented HIV-1 infection and confirmed SARS-CoV-2 infection by documented, or patient-reported, positive result on PCR testing of a nasopharyngeal or respiratory sample, before 1st April 2021.
- PLWHIV without COVID-19 controls (Type: None): Patients at least 18 years of age with documented HIV-1 infection.
- HIV seronegative patients with COVID-19 controls (Type: None): Patients at least 18 years of age with confirmed SARS-CoV-2 infection by documented, or patient-reported, positive result on PCR testing of a nasopharyngeal or respiratory sample, before 1st April 2021.

Based on this trial design, predict the completion outcome and termination type (if applicable).